http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021401853-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20c9a3d1493f5be459439df9a8557efd |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
filingDate | 2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a06b2c6f022706bb57c14a19e37737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e61d9a1fb9e45f787e11c8bbc5f919d |
publicationDate | 2021-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2021401853-A1 |
titleOfInvention | Methods of treating neurodevelopmental disorders |
abstract | The invention relates to the treatment of neurodevelopmental disorders using an inhibitor of rho kinase. Preferred methods contemplate the treatment of infants and children. Certain embodiments involve treating a neurodevelopmental disorder is caused by defects of metabolism, including defects of amino acid transport or metabolism, acid-base balance, carbohydrate transport or metabolism, metal homeostasis, neurotransmitter metabolism, or fatty acid transport or metabolism. Methods address a variety of conditions caused by changes in the genetic material that affect the structure and/or expression of certain genes. Preferred methods treat Down syndrome, Fragile X syndrome, oligophrenin 1 deficiency, Rett syndrome, autistic disorder, Asperger's syndrome, pervasive developmental disorder not otherwise specified, and other autism spectrum disorders. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216537-A1 |
priorityDate | 2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.